InsidersTradesSigma
Follow the Imugene Limited stock price and the full insider trade history of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, Imugene Limited has published 5 public disclosures. Market capitalisation: €35.7m. The latest transaction was filed on 1 September 2026 (Other). Among the most active insiders: 2. Details of voting power. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Imugene Limited 是一家生物制药公司，专注于开发癌症免疫治疗药物。该公司在澳大利亚证券交易所上市，股票代码为 IMU。